University Of Maryland, Baltimore
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1807-01-01
- Employees
- 7.3K
- Market Cap
- -
- Website
- http://www.umaryland.edu
Ultrasound and CT to Measure Muscle in Hip OA
Withdrawn
- Conditions
- Hip Osteoarthritis
- First Posted Date
- 2019-08-19
- Last Posted Date
- 2021-05-04
- Lead Sponsor
- University of Maryland, Baltimore
- Registration Number
- NCT04061499
- Locations
- 🇺🇸
Baltimore VA Medical Center, Baltimore, Maryland, United States
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
Phase 2
Recruiting
- Conditions
- Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult
- Interventions
- Drug: Cladribine, Cytarabine, and Granulocyte-Colony Stimulating Factor with Fractionated Gemtuzumab Ozogamicin (CLAG-GO)
- First Posted Date
- 2019-08-08
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 39
- Registration Number
- NCT04050280
- Locations
- 🇺🇸
Larissa Sanglard, Baltimore, Maryland, United States
Itraconazole Oral Absorption
Phase 4
Completed
- Conditions
- Fungal Infection
- Interventions
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 17
- Registration Number
- NCT04035187
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Home Exercise Program for Homebound Older Adults
Not Applicable
Completed
- Conditions
- Aging
- Interventions
- Behavioral: HEX
- First Posted Date
- 2019-07-26
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 19
- Registration Number
- NCT04034888
- Locations
- 🇺🇸
University of Maryland, Baltimore, Maryland, United States
Effects of Early Community Services on Child and Family Development
Not Applicable
Active, not recruiting
- Conditions
- Child Development
- Interventions
- Other: Nurse Home Visiting Program
- First Posted Date
- 2019-07-15
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 277
- Registration Number
- NCT04019977
- Locations
- 🇺🇸
UMaryland, Baltimore, Maryland, United States
🇺🇸Sinai Hospital, Baltimore, Maryland, United States
Youth Opioid Recovery Support: Improving Care Systems
Not Applicable
Completed
- Conditions
- Opioid-Related Disorders
- Interventions
- Behavioral: Youth Opioid Recovery Support service model
- First Posted Date
- 2019-07-10
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 44
- Registration Number
- NCT04015115
- Locations
- 🇺🇸
Mountain Manor Treatment Center, Baltimore, Maryland, United States
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
Phase 1
Completed
- Conditions
- SchizophreniaSchizoaffective DisorderSchizophreniform Disorder
- Interventions
- First Posted Date
- 2019-07-09
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 88
- Registration Number
- NCT04013555
- Locations
- 🇺🇸
Maryland Psychiatric Research Center (MPRC) ; the Treatment Research Program (TRP), Catonsville, Maryland, United States
Cigarette Smoking in Smokers With and Without Schizophrenia
Not Applicable
Recruiting
- Conditions
- SchizophreniaTobacco Dependence
- Interventions
- Combination Product: Sampling Research Cigarettes
- First Posted Date
- 2019-06-27
- Last Posted Date
- 2022-10-10
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 90
- Registration Number
- NCT04001114
- Locations
- 🇺🇸
Maryland Psychiatric Research Center, Catonsville, Maryland, United States
Salmonella Conjugates CVD 1000: Study of Responses to Vaccination with Trivalent Invasive Salmonella Disease Vaccine
Phase 1
Completed
- Conditions
- Risk Reduction
- Interventions
- Biological: Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)Biological: Trivalent Invasive Salmonella Disease Vaccine (12 µg)Biological: Trivalent Invasive Salmonella Disease Vaccine (25 µg)Biological: Trivalent Invasive Salmonella Disease Vaccine (highest, well-tolerated dose among Cohorts A-C)Other: Placebo
- First Posted Date
- 2019-06-11
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 96
- Registration Number
- NCT03981952
- Locations
- 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
Blood Donor CVD 5000
- First Posted Date
- 2019-06-03
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- University of Maryland, Baltimore
- Target Recruit Count
- 150
- Registration Number
- NCT03971669
- Locations
- 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath